These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 14061831)

  • 41. Effect of organic nitrates on myocardial oxygen consumption in vitro.
    Levy JV
    Br J Pharmacol; 1970 Apr; 38(4):743-8. PubMed ID: 4986041
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is a new physiopathologic interpretation of obstructive diseases of the arteries possible? Two cases of thromboangiitis obliterans treated with polarizing solution and coronary vasodilators.
    Vega Diaz F; Perez Casar F; Alonso JL; Esteban L; Martin E; Salazar JS
    Angiology; 1968 Dec; 19(12):633-51. PubMed ID: 4973295
    [No Abstract]   [Full Text] [Related]  

  • 43. [Treatment of coronary circulation disorders with Adenopurine].
    Mahr H
    Munch Med Wochenschr; 1966 Jan; 108(4):205-9. PubMed ID: 6013263
    [No Abstract]   [Full Text] [Related]  

  • 44. Pentaerythrityl tetranitrate (PETN): a better nitrate?
    Rutherford E; Struthers AD
    Eur Heart J; 2019 Dec; 40(46):e23-e25. PubMed ID: 24126881
    [No Abstract]   [Full Text] [Related]  

  • 45. Potency and in vitro tolerance of organic nitrates: partially denitrated metabolites contribute to the tolerance-devoid activity of pentaerythrityl tetranitrate.
    Koenig A; Lange K; Konter J; Daiber A; Stalleicken D; Glusa E; Lehmann J
    J Cardiovasc Pharmacol; 2007 Jul; 50(1):68-74. PubMed ID: 17666918
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of coronary insufficiency. Clinical evaluation of a vasodilator agent and tranquilizer drug combination (Ro 4-6486)].
    Buzzi A
    Med Panam; 1963 Aug; 21(4):97-9. PubMed ID: 5900011
    [No Abstract]   [Full Text] [Related]  

  • 47. Further observations of cardiovascular effects of pentaerythritol tetranitrate in animals and man.
    WINSOR T; SCOTT CC
    Am Heart J; 1955 Mar; 49(3):414-27. PubMed ID: 14349856
    [No Abstract]   [Full Text] [Related]  

  • 48. Is a new physiopathologic interpretation of obstructive diseases of the arteries possible? Two cases of thromboangiitis obliterans treated with polarizing solution and coronary vasodilators.
    Diaz FV; Casar FP; Alonso JL; Esteban L; Martin E; Salazar JS
    Angiology; 1968 Dec; 19(11):633-51. PubMed ID: 4989007
    [No Abstract]   [Full Text] [Related]  

  • 49. [Special place of PETN among nitrates. No tolerance development, fewer headaches].
    Münzel T
    MMW Fortschr Med; 2008 Jan; 150(1-2):41. PubMed ID: 18300643
    [No Abstract]   [Full Text] [Related]  

  • 50. NEW and nonofficial remedies: pentaerythritol tetranitrate.
    J Am Med Assoc; 1953 Jan; 151(5):386. PubMed ID: 13011009
    [No Abstract]   [Full Text] [Related]  

  • 51. The pharmacodynamics and biotransformation of pentaerythritol trinitrate in man.
    Davidson IW; Rollins FO; DiCarlo FJ; Miller HS
    Clin Pharmacol Ther; 1971; 12(6):972-81. PubMed ID: 5134999
    [No Abstract]   [Full Text] [Related]  

  • 52. [Experiences with a combined glycoside-nitrite treatment in chronic coronary insufficiency].
    Wick T
    Med Welt; 1969 Oct; 42():2327-30. PubMed ID: 5355678
    [No Abstract]   [Full Text] [Related]  

  • 53. Simultaneous semiautomated determination of pentaerythritol tetranitrate or mannitol hexanitrate and phenobarbital in tablets.
    Brown DJ; Cook DG
    J Pharm Sci; 1973 Oct; 62(10):1713-7. PubMed ID: 4752121
    [No Abstract]   [Full Text] [Related]  

  • 54. [Combined treatment of chronic coronary disease with pentaerythritol tetranitrate and propranolol].
    Florkiewicz H; Rymar B; Markiewicz M; Trojnar R; Rumiński W
    Pol Tyg Lek; 1981 Apr; 36(14):501-3. PubMed ID: 7267422
    [No Abstract]   [Full Text] [Related]  

  • 55. [Change in the action of the vagus nerve on the coronary vessels under the influence of vasodilator agents].
    SAMOILOVA ZT
    Farmakol Toksikol; 1962; 25():569-73. PubMed ID: 13991332
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of transdermal nitroglycerin on inflammatory mediators in patients with peripheral atherosclerotic vascular disease.
    de Berrazueta JR; Sampedro I; Garcia-Unzueta MT; Llorca J; Bustamante M; Amado JA
    Am Heart J; 2003 Oct; 146(4):E14. PubMed ID: 14564337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CHEMOTHERAPY OF CORONARY ARTERY DISEASE: A DOUBLE-BLIND CROSSOVER STUDY OF PETN AND PENTRIUM.
    TALBOT FJ
    Med Ann Dist Columbia; 1965 Jan; 34():19-22. PubMed ID: 14281449
    [No Abstract]   [Full Text] [Related]  

  • 58. A study of the therapeutic action and toxicity of pentaerythritol tetranitrate.
    PERLMAN A
    Angiology; 1952 Feb; 3(1):16-9. PubMed ID: 14903605
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of nitroglycerin or pentaerithrityl tetranitrate treatment on the gene expression in rat hearts: evidence for cardiotoxic and cardioprotective effects.
    Pautz A; Rauschkolb P; Schmidt N; Art J; Oelze M; Wenzel P; Förstermann U; Daiber A; Kleinert H
    Physiol Genomics; 2009 Jul; 38(2):176-85. PubMed ID: 19417013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Therapy of vascular syndromes, particularly arteriolar, with pentaerythritol tetranitrate].
    MARCHE J
    Angeiol Ann Soc Fr Angeiol Histopathol; 1952 Dec; 59(22):45-6. PubMed ID: 13021408
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.